Informed consent
Item
Provision of informed consent prior to any study specific procedures
boolean
C0021430 (UMLS CUI-1)
Gender
Item
Female or male
boolean
C0079399 (UMLS CUI-1)
Age
Item
Aged at least 18 years
boolean
C0001779 (UMLS CUI-1)
Pregnancy
Item
Females of child-bearing potential must have a negative urine pregnancy test at enrolment
boolean
C0549206 (UMLS CUI-1)
Contraceptive
Item
Females of child-bearing potential must be willing to use reliable contraception
boolean
C0009871 (UMLS CUI-1)
Acute coronary syndrome
Item
Index event of non-ST or ST segment elevation ACS.
boolean
Clopidogrel contraindicated
Item
Contraindication or other reason that clopidogrel should not be administered
boolean
C1319916 (UMLS CUI-1)
Ticagrelor contraindicated
Item
Contraindication or other reason that ticagrelor should not be administered
boolean
C1999375 (UMLS CUI-1)
C0522473 (UMLS CUI-2)
Oral anticoagulants
Item
Oral anticoagulation therapy within 30 days prior to randomisation or cannot be stopped
boolean
C0354604 (UMLS CUI-1)
GPIIb/IIIa receptor antagonist
Item
GP IIb/IIIa receptor antagonists therapy within 30 days prior to randomisation or cannot be stopped
boolean
C3640054 (UMLS CUI-1)
Ticagrelor
Item
Ticagrelor within 14 days prior to randomisation
boolean
C1999375 (UMLS CUI-1)
Clopidogrel
Item
Clopidogrel within 14 days prior to randomisation
boolean
C0070166 (UMLS CUI-1)
Thienopyridines
Item
P2Y12 inhibitors within 14 days prior to randomisation
boolean
C2936588 (UMLS CUI-1)
Hemodialysis
Item
Requires dialysis
boolean
C0019004 (UMLS CUI-1)
NSAID
Item
Nonselective non-steroidal anti-inflammatory drugs therapy that cannot be stopped
boolean
C0003211 (UMLS CUI-1)
Prostacycline
Item
prostacyclins (PGI2) therapy that cannot be stopped
boolean
C2825061 (UMLS CUI-1)